TrialInternational immunopharmacology2021

Mometasone furoate nasal spray in the treatment of patients with COVID-19 olfactory dysfunction: A randomized, double blind clinical trial.

Hossein Kasiri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.